Cansino Biologics

Showing 1 of 4 from 4 results
Cansino Biologics - Total results - 4
CanSino Biologics to begin final phase of human trials for its COVID-19 vaccine in Saudi Arabia
science

CanSino Biologics to begin final phase of human trials for its COVID-19 vaccine in Saudi Arabia

This final leg of human vaccine trials will recruit 5,000 volunteers above age 18 in Riyadh, Dammam and Mecca.

COVID-19 research roundup: Multiple potential vaccines show promise; doctors say hands-only CPR safe during pandemic
science

COVID-19 research roundup: Multiple potential vaccines show promise; doctors say hands-only CPR safe during pandemic

Hands-only CPR carries low risk of transmitting COVID-19, and bystanders witnessing a cardiac arrest shouldn't be afraid to perform it, doctors say.

China's CanSino in talks with other countries, including Russia, Brazil, to launch Phase III trial of COVID-19 vaccine
World

China's CanSino in talks with other countries, including Russia, Brazil, to launch Phase III trial of COVID-19 vaccine

CanSino's COVID-19 candidate, Ad5-nCov, became the first in China to move into human testing in March but is running behind other potential vaccines in terms of trial progress.

COVID-19 vaccine: Potential coronavirus vaccine candidate from China shows promise in animal tests
World

COVID-19 vaccine: Potential coronavirus vaccine candidate from China shows promise in animal tests

More than 100 potential COVID-19 vaccines are in various stages of development around the world.